Hims & Hers Health, the telehealth platform focused on personalized treatments for hair loss, sexual health, and weight management, reported Q2 2026 results on August 10 with raised full-year revenue guidance to $3.1–3.3 billion amid subscriber growth to nearly 2.9 million. Traders monitoring the next earnings call in November will focus on updates to GLP-1 branded offerings, margin recovery from ongoing investments in AI-driven personalization, diagnostics, and international expansion via the Eucalyptus acquisition. Recent quarters show revenue growth tempered by near-term EBITDA pressure as the company shifts toward higher-margin branded products and platform scaling, creating uncertainty around the pace of profitability improvement and competitive positioning against other digital health providers.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया$23,202 वॉल्यूम
Quarter 20+ times
Yes
Subscriber 15+ times
Yes
Platform 10+ times
Yes
Fiscal 10+ times
No
Peptide 5+ times
Yes
GLP-1
Yes
Testosterone
Yes
Eucalyptus
Yes
Longevity
Yes
Wearable
Yes
Europe
Yes
Amazon
No
Regulation
No
-No Qualifying Event-
No
$23,202 वॉल्यूम
Quarter 20+ times
Yes
Subscriber 15+ times
Yes
Platform 10+ times
Yes
Fiscal 10+ times
No
Peptide 5+ times
Yes
GLP-1
Yes
Testosterone
Yes
Eucalyptus
Yes
Longevity
Yes
Wearable
Yes
Europe
Yes
Amazon
No
Regulation
No
-No Qualifying Event-
No
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
बाज़ार खुला: Aug 7, 2026, 7:02 PM ET
रिज़ॉल्वर
0x65070BE91...परिणाम प्रस्तावित: Yes
कोई विवाद नहीं
अंतिम परिणाम: Yes
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
If this event is definitely cancelled, or otherwise is not aired by August 11, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Event+Mentions+Contract+DeFi.pdf
रिज़ॉल्वर
0x65070BE91...परिणाम प्रस्तावित: Yes
कोई विवाद नहीं
अंतिम परिणाम: Yes
Hims & Hers Health, the telehealth platform focused on personalized treatments for hair loss, sexual health, and weight management, reported Q2 2026 results on August 10 with raised full-year revenue guidance to $3.1–3.3 billion amid subscriber growth to nearly 2.9 million. Traders monitoring the next earnings call in November will focus on updates to GLP-1 branded offerings, margin recovery from ongoing investments in AI-driven personalization, diagnostics, and international expansion via the Eucalyptus acquisition. Recent quarters show revenue growth tempered by near-term EBITDA pressure as the company shifts toward higher-margin branded products and platform scaling, creating uncertainty around the pace of profitability improvement and competitive positioning against other digital health providers.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया
बाहरी लिंक से सावधान रहें।
बाहरी लिंक से सावधान रहें।
अक्सर पूछे जाने वाले प्रश्न